Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ESTIM-UL: FES for Upper Limb Recovery After Stroke

NCT: NCT07513714 · NOT_YET_RECRUITING

NCT IDNCT07513714
StatusNOT_YET_RECRUITING
Start Date2026-05-01
Completion2026-12-01

Brief Summary

Stroke is a leading cause of long-term disability, frequently resulting in impaired upper limb motor function and spasticity. Although Botulinum Toxin Type A (BoNT-A) is effective in reducing focal spasticity, functional recovery of the upper limb often remains limited without intensive, task-specific rehabilitation. Functional Electrical Stimulation (FES), when synchronized with voluntary movement during Task-Oriented Training, may enhance motor recovery by facilitating muscle activation and neuroplasticity. This randomized controlled trial aims to evaluate whether FES combined with Task-Oriented Training is superior to conventional Task-Oriented Training alone in improving upper limb function in post-stroke patients treated with BoNT-A.

Frequently Asked Questions

What is ESTIM-UL: FES for Upper Limb Recovery After Stroke?

ESTIM-UL: FES for Upper Limb Recovery After Stroke is a clinical trial registered under NCT07513714. Current status: NOT_YET_RECRUITING.

What is the status of NCT07513714?

The current status of NCT07513714 (ESTIM-UL: FES for Upper Limb Recovery After Stroke) is: NOT_YET_RECRUITING.

When did ESTIM-UL: FES for Upper Limb Recovery After Stroke start?

ESTIM-UL: FES for Upper Limb Recovery After Stroke started on 2026-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.